Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Assets
Cash and cash equivalents	$ 7,817	$ 454
Finance receivables held for sale, at a lower of amortized cost or fair value	50,306	0
Finance receivables, net of unearned discounts and fees and accrued interest receivable	0	124,315
Less: Allowance for credit losses	0	(17,396)
Finance receivables, net	0	106,919
Repossessed assets held for sale, at a lower of carrying value or fair value less cost to sell	395	1,491
Prepaid expenses and other assets	390	316
Income taxes receivable	915	946
Property and equipment, net	168	222
Total assets	59,991	110,348
Liabilities and shareholders’ equity
Line of credit, net of debt issuance costs	0	28,936
Accounts payable, accrued expenses, and other liabilities	938	1,603
Total liabilities	938	30,539
Commitments and contingencies (see Note 9)
Shareholders’ equity
Preferred stock, no par: 5,000 shares authorized; none issued	0	0
Common stock, no par: 50,000 shares authorized; 12,658 shares issued, 7,289 shares outstanding as of December 31, 2023 and March 31, 2023	35,267	35,223
Treasury stock: 5,369 common shares, at cost	(76,794)	(76,794)
Retained earnings	100,580	121,380
Total shareholders’ equity	59,053	79,809
Total liabilities and shareholders’ equity	$ 59,991	$ 110,348